This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
RVS | Ann: CS International 2019 Presentation | 26/03/19 | 0 | 77 | |||
|
|||||||
RVS | Q&A video interview with Revasum President & CEO, Jerry Cutini | 26/03/19 | 0 | 61 | |||
|
|||||||
RVS | Ann: Revasum CTO to present at CS International in Brussels | 22/03/19 | 0 | 131 | |||
|
|||||||
RVS | Ann: Correction - TechKnow Invest Roadshow 2019 Presentation | 19/03/19 | 0 | 6.5K | |||
|
|||||||
RVS | Ann: Revasum TechKnow Invest Roadshow 2018 Presentation | 18/03/19 | 0 | 567 | |||
|
|||||||
RVS | Ann: Revasum to Present at TechKnow Invest Roadshow | 07/03/19 | 0 | 218 | |||
|
|||||||
RVS | Ann: FY2018 Results Presentation | 26/02/19 | 1 | 577 | |||
|
|||||||
RVS | Ann: Appendix 4G | 26/02/19 | 0 | 113 | |||
|
See All Discussions